⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NSRX News
Nasus Pharma Ltd.
Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
globenewswire.com
NSRX
Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
NSRX
Nasus Pharma Announces Transition of Chief Financial Officer
globenewswire.com
NSRX
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
globenewswire.com
NSRX
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
globenewswire.com
NSRX
ASRT
Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
globenewswire.com
NSRX
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)
globenewswire.com
NSRX
Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
globenewswire.com
NSRX
Nasus Pharma to Participate in Upcoming Investor Conferences
globenewswire.com
NSRX
RedChip's Biotech Virtual Investor Conference Replays Now Available
accessnewswire.com
INAB
DMAC
NSRX
CLDI